\BOOKMARK [0][-]{chapter*.2}{LIST OF TABLES}{}% 1
\BOOKMARK [0][-]{chapter*.3}{LIST OF FIGURES}{}% 2
\BOOKMARK [0][-]{chapter.1}{I Introduction}{}% 3
\BOOKMARK [1][-]{section.1.1}{I.1 The sampling and scoring methods used by the Rosetta software suite}{chapter.1}% 4
\BOOKMARK [2][-]{subsection.1.1.1}{I.1.1 Sampling strategies for backbone degrees of freedom}{section.1.1}% 5
\BOOKMARK [2][-]{subsection.1.1.2}{I.1.2 Sampling strategies for side-chain degrees of freedom}{section.1.1}% 6
\BOOKMARK [2][-]{subsection.1.1.3}{I.1.3 Rosetta energy function}{section.1.1}% 7
\BOOKMARK [3][-]{subsubsection.1.1.3.1}{I.1.3.1 Knowledge based centroid energy function}{subsection.1.1.3}% 8
\BOOKMARK [3][-]{subsubsection.1.1.3.2}{I.1.3.2 Knowledge based all atom energy function}{subsection.1.1.3}% 9
\BOOKMARK [1][-]{section.1.2}{I.2 Protein design using Rosetta}{chapter.1}% 10
\BOOKMARK [2][-]{subsection.1.2.1}{I.2.1 De novo protein design}{section.1.2}% 11
\BOOKMARK [2][-]{subsection.1.2.2}{I.2.2 Redesign of existing proteins}{section.1.2}% 12
\BOOKMARK [1][-]{section.1.3}{I.3 Existing challenges with protein surface design}{chapter.1}% 13
\BOOKMARK [2][-]{subsection.1.3.1}{I.3.1 Electrostatic energy is insufficient to predict the impact of protein surface mutations}{section.1.3}% 14
\BOOKMARK [2][-]{subsection.1.3.2}{I.3.2 Computationally designed proteins frequently aggregate unless "supercharged"}{section.1.3}% 15
\BOOKMARK [1][-]{section.1.4}{I.4 The history of ligand docking}{chapter.1}% 16
\BOOKMARK [2][-]{subsection.1.4.1}{I.4.1 Early attempts at hand-docking ligands using physical models}{section.1.4}% 17
\BOOKMARK [2][-]{subsection.1.4.2}{I.4.2 An overview of influential protein-ligand docking methods}{section.1.4}% 18
\BOOKMARK [3][-]{subsubsection.1.4.2.1}{I.4.2.1 DOCK}{subsection.1.4.2}% 19
\BOOKMARK [3][-]{subsubsection.1.4.2.2}{I.4.2.2 GRID}{subsection.1.4.2}% 20
\BOOKMARK [3][-]{subsubsection.1.4.2.3}{I.4.2.3 The importance of protein and ligand flexibility}{subsection.1.4.2}% 21
\BOOKMARK [3][-]{subsubsection.1.4.2.4}{I.4.2.4 FlexX and GOLD}{subsection.1.4.2}% 22
\BOOKMARK [3][-]{subsubsection.1.4.2.5}{I.4.2.5 Glide}{subsection.1.4.2}% 23
\BOOKMARK [1][-]{section.1.5}{I.5 The history of RosettaLigand}{chapter.1}% 24
\BOOKMARK [2][-]{subsection.1.5.1}{I.5.1 RosettaLigand is capable of successfully predicting binding based on comparative models}{section.1.5}% 25
\BOOKMARK [2][-]{subsection.1.5.2}{I.5.2 Applications of RosettaLigand to drug discovery}{section.1.5}% 26
\BOOKMARK [1][-]{section.1.6}{I.6 Computational ligand docking has inconsistent predictive power}{chapter.1}% 27
\BOOKMARK [1][-]{section.1.7}{I.7 Artificial Neural Network techniques have proven valuable for extracting complex signals}{chapter.1}% 28
\BOOKMARK [1][-]{section.1.8}{I.8 Over-training and over-fitting are common pitfalls in the use of ANN!s for pattern recognition}{chapter.1}% 29
\BOOKMARK [2][-]{subsection.1.8.1}{I.8.1 Deep networks and node dropout as novel methods for improving network generalizability}{section.1.8}% 30
\BOOKMARK [1][-]{section.1.9}{I.9 Using ANN!s to make predictions regarding drug activity is a major area of current research}{chapter.1}% 31
